Drug Shortage Report for METHOTREXATE INJECTION BP
| Report ID | 225235 |
| Drug Identification Number | 02327236 |
| Brand name | METHOTREXATE INJECTION BP |
| Common or Proper name | METHOTREXATE |
| Company Name | ACCORD HEALTHCARE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | METHOTREXATE |
| Strength(s) | 25MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRATHECAL INTRAMUSCULAR INTRA-ARTERIAL INTRACEREBROVENTRICULAR INTRACEREBROVENTRICULAR INTRAVENOUS INTRATHECAL INTRAMUSCULAR INTRA-ARTERIAL |
| Packaging size | 2ML |
| ATC code | L01BA |
| ATC description | ANTIMETABOLITES |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2024-10-01 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2024-04-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-04-16 | French | Compare |
| v1 | 2024-04-16 | English | Compare |
Showing 1 to 2 of 2